1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary

3.1. Introduction
3.2. Market Outlook
3.3. Drug Class Outlook
3.4. Age Group Outlook
3.5. Distribution Channel Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview

4.1. Introduction

5. Market Dynamics

5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Market Insights

6.1. Porters Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Cumulative Impact of COVID-19
6.3. Client Customizations

7. Global Anti-obesity Prescription Drugs Market, By Drug Class

7.1. Introduction
7.2. Bupropion and Naltrexone
7.3. Liraglutide
7.4. Lorcaserin
7.5. Orlistat
7.6. Phentermine and Topiramate

8. Global Anti-obesity Prescription Drugs Market, By Age Group

8.1. Introduction
8.2. Adult
8.3. Pediatric

9. Global Anti-obesity Prescription Drugs Market, By Distribution Channel

9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy

10. Americas Anti-obesity Prescription Drugs Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Anti-obesity Prescription Drugs Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand

12. Europe, Middle East & Africa Anti-obesity Prescription Drugs Market

12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles

14.1. Alizyme
14.2. Arena Pharmaceuticals, Inc
14.3. Boehringer Ingelheim
14.4. F Hoffmann La Roche Ltd
14.5. GlaxoSmithKline
14.6. Novo Nordisk A/s
14.7. Orexigen Therapeutics, Inc
14.8. VIVUS, Inc

15. Appendix

15.1. Discussion Guide

List of Figures

FIGURE 1. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2019 VS 2025 (USD MILLION)
FIGURE 5. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2019 VS 2025 (USD MILLION)
FIGURE 6. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019 VS 2025 (USD MILLION)
FIGURE 7. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 8. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 9. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 10. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2019 VS 2025 (%)
FIGURE 15. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2019 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 17. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY BUPROPION AND NALTREXONE, 2019 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY LIRAGLUTIDE, 2019 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY LORCASERIN, 2019 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY ORLISTAT, 2019 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY PHENTERMINE AND TOPIRAMATE, 2019 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2019 VS 2025 (%)
FIGURE 23. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2019 VS 2025 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2025
FIGURE 25. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY ADULT, 2019 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY PEDIATRIC, 2019 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019 VS 2025 (%)
FIGURE 28. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025
FIGURE 30. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2019 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2019 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2019 VS 2025 (USD MILLION)
FIGURE 33. AMERICAS ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 34. AMERICAS ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 36. ARGENTINA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 37. BRAZIL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 38. CANADA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 39. MEXICO ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 40. UNITED STATES ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 41. ASIA-PACIFIC ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 42. ASIA-PACIFIC ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 44. AUSTRALIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 45. CHINA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 46. INDIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 47. INDONESIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 48. JAPAN ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 49. MALAYSIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 50. PHILIPPINES ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 51. SOUTH KOREA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 52. THAILAND ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 56. FRANCE ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 57. GERMANY ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 58. ITALY ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 59. NETHERLANDS ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 60. QATAR ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 61. RUSSIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 62. SAUDI ARABIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 63. SOUTH AFRICA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 64. SPAIN ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 65. UNITED ARAB EMIRATES ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 66. UNITED KINGDOM ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
FIGURE 67. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 68. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 69. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 3. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 4. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY BUPROPION AND NALTREXONE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 5. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY LIRAGLUTIDE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 6. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY LORCASERIN, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 7. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY ORLISTAT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 8. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY PHENTERMINE AND TOPIRAMATE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 9. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 10. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY ADULT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 11. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY PEDIATRIC, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 12. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 13. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 14. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 15. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 16. AMERICAS ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 17. AMERICAS ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 18. AMERICAS ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 19. AMERICAS ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 20. ARGENTINA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 21. ARGENTINA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 22. ARGENTINA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 23. BRAZIL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 24. BRAZIL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 25. BRAZIL ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 26. CANADA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 27. CANADA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 28. CANADA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 29. MEXICO ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 30. MEXICO ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 31. MEXICO ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 32. UNITED STATES ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 33. UNITED STATES ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 34. UNITED STATES ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 35. ASIA-PACIFIC ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 36. ASIA-PACIFIC ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 37. ASIA-PACIFIC ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 38. ASIA-PACIFIC ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 39. AUSTRALIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 40. AUSTRALIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 41. AUSTRALIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 42. CHINA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 43. CHINA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 44. CHINA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 45. INDIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 46. INDIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 47. INDIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 48. INDONESIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 49. INDONESIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 50. INDONESIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 51. JAPAN ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 52. JAPAN ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 53. JAPAN ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 54. MALAYSIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 55. MALAYSIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 56. MALAYSIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 57. PHILIPPINES ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 58. PHILIPPINES ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 59. PHILIPPINES ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 60. SOUTH KOREA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 61. SOUTH KOREA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 62. SOUTH KOREA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 63. THAILAND ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 64. THAILAND ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 65. THAILAND ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 70. FRANCE ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 71. FRANCE ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 72. FRANCE ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 73. GERMANY ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 74. GERMANY ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 75. GERMANY ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 76. ITALY ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 77. ITALY ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 78. ITALY ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 79. NETHERLANDS ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 80. NETHERLANDS ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 81. NETHERLANDS ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 82. QATAR ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 83. QATAR ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 84. QATAR ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 85. RUSSIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 86. RUSSIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 87. RUSSIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 88. SAUDI ARABIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 89. SAUDI ARABIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 90. SAUDI ARABIA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 91. SOUTH AFRICA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 92. SOUTH AFRICA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 93. SOUTH AFRICA ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 94. SPAIN ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 95. SPAIN ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 96. SPAIN ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 99. UNITED ARAB EMIRATES ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 100. UNITED KINGDOM ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DRUG CLASS, 2017-2025 (USD MILLION)
TABLE 101. UNITED KINGDOM ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY AGE GROUP, 2017-2025 (USD MILLION)
TABLE 102. UNITED KINGDOM ANTI-OBESITY PRESCRIPTION DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
TABLE 103. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET: SCORES
TABLE 104. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET: BUSINESS STRATEGY
TABLE 105. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET: PRODUCT SATISFACTION
TABLE 106. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET: RANKING
TABLE 107. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET: MERGER & ACQUISITION
TABLE 108. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 109. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 110. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET: INVESTMENT & FUNDING
TABLE 111. GLOBAL ANTI-OBESITY PRESCRIPTION DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION

Companies Mentioned

Alizyme
Arena Pharmaceuticals, Inc
Boehringer Ingelheim
F Hoffmann La Roche Ltd
GlaxoSmithKline
Novo Nordisk A/s
Orexigen Therapeutics, Inc
VIVUS, Inc